Authors:
Allsop, D
Gibson, G
Martin, IK
Moore, S
Turnbull, S
Twyman, LJ
Citation: D. Allsop et al., 3-p-Toluoyl-2-[4 '-(3-diethylaminopropoxy)-phenyl]-benzofuran and 2-[4 '-(3-diethylaminopropoxy)-phenyl]-benzofuran do not act as surfactants or micelles when inhibiting the aggregation of beta-amyloid peptide, BIOORG MED, 11(2), 2001, pp. 255-257
Authors:
Turnbull, S
Tabner, BJ
El-Agnaf, OMA
Twyman, LJ
Allsop, D
Citation: S. Turnbull et al., New evidence that the Alzheimer beta-amyloid peptide does not spontaneously form free radicals: An ESR study using a series of spin-traps, FREE RAD B, 30(10), 2001, pp. 1154-1162
Authors:
Turnbull, S
Tabner, BJ
El-Agnaf, OMA
Moore, S
Davies, Y
Allsop, D
Citation: S. Turnbull et al., alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro, FREE RAD B, 30(10), 2001, pp. 1163-1170
Authors:
Steiner, G
Hamsten, A
Hosking, J
Stewart, D
McLaughlin, P
Gladstone, P
Sole, M
Syvanne, M
Hamsten, A
Camelon, K
Schloegl, G
Genest, J
Reeves, F
Savard, R
Letarte, A
Bellavance, N
Touchette, J
Latour, Y
Marchand, P
Rondeau, C
Rivard-Gervais, N
Belanger, A
Hamel, D
Dumas, R
Sandri, M
Morin, N
Caponi, E
Barbeau, C
Gauthier, S
Ooi, TC
Davies, RF
Braaten, JT
Baker, A
Favreau, C
Collar, C
Zinman, B
Gladstone, P
Aldridge, H
Donat, DJ
Tsui, E
Barnie, A
DiMonte, L
MacLean, S
Bond, M
Camelon, K
Martin, C
Zawacki, R
Dziuran, K
Gouveia, MR
Taskinen, MR
Nieminen, M
Nikkila, K
Virtanen, K
Makimattila, S
Malmstrom, R
Kohtamaki, H
Jamsen, P
Salo, A
Puupponen, M
Kesaniemi, A
Ikaheimo, M
Ukkola, O
Salmela, P
Savolainen, M
Huikuri, H
Airaksinen, J
Koistinen, J
Mannermaa, L
Ukkola, L
Ketonen, K
Silaste, ML
Salovaara, A
Efendic, S
Svane, B
Hellekant, C
Bavenholm, P
Karlen, A
Hadell, K
Hamsten, A
Franson, K
Mohlkert, D
Nordlander, R
Ehrenstig, L
Tan, MH
Title, LM
Johnstone, D
Winch, S
Higgins-Bowser, I
Shlossberg, A
Murdock, H
Elliott, T
Fung, A
Jalbert, A
Leung, S
Turnbull, S
Norman, E
Valensi, P
Farez, C
Tavolaro, O
Sachs, RN
Sedjari, F
Laakso, M
Kettunen, R
Eranen, J
Lehto, S
Raisanen, R
Jantunen, A
Valve, R
Toivanen, A
Frohlich, J
Vannetta, H
Bowden, F
Seccombe, DW
Ehnholm, C
Gref, CG
Ikonen, M
Sundvall, J
Seccombe, DW
McGuinness, C
Ho, A
Hamilton, J
Pritchard, H
McLaughlin, P
Gladstone, P
Allard, N
Bond, M
Bui, S
Van der Wal, H
Hosking, J
Davis, CE
Tyroler, HA
Stewart, D
Curtis, RC
Miles, M
Khaltaev, N
Sole, M
Kirkeeide, R
Frick, H
Hata, Y
Rifkind, B
Zimmet, P
Gent, M
Schonfeld, G
de Bono, D
Reeves, F
Carter, A
Ansquer, JC
Fraitag, B
Guivarc'h, PH
Irvine, A
Jacovella, J
Munoz, A
Rode, H
Yacine, A
Asmar-Kristiansen, D
Bonnefous, F
Belanger, F
Bond, M
Brown, M
DeLorme, L
Galos, C
Jenkins, R
Lanoue, C
Moussalli, R
Murtomaki, E
Zandomenighi, F
Citation: G. Steiner et al., Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study, LANCET, 357(9260), 2001, pp. 905-910
Authors:
Heptonstall, J
Turnbull, S
Henderson, D
Morgan, D
Harling, K
Scott, G
Citation: J. Heptonstall et al., Sharps injury! A review of controversial areas in the management of sharpsaccidents, J HOSP INF, 43, 1999, pp. S219-S223